SlideShare ist ein Scribd-Unternehmen logo
1 von 2
Naveen Pawar
NAVEEN KUMAR PAWAR E-mail: pnaveenkumar20@gmail.com
Pune,India Contact no: +91-7030897089
Summary
 Involved in writing and review of various safety reports for global regulatory submissions for Sciformix’s clients, including
Canadian Annual Reports (CARs), Addendum Reports (ACOs and Adhocs), Periodic Benefit Risk Evaluation Reports
(PBRERs), Periodic Safety Update Reports (PSURs), Periodic Adverse Drug Experience Reports (PADERs), Bridging
reports and other clinical documents
Education
 M. Sc. (Biotechnology), PondicherryUniversity
 B. Sc. (Biotechnology), Loyola Academy(Osmania University)
Publications, Seminars & Presentations
Naveen Kumar Pawar,N Arumugam. Leafextract of Centratherumpunctatum Cass.exhibits anti-microbial,anti-proliferative
and anti-oxidant properties. Asian journal ofclinical and pharmaceutical research (published July2011).
Work Experience
April 2014 – Present Medical writer , Sciformix Technologies, Pune
Sciformix
Safety Writing and Regulatory Affairs
• Preparing/Co-authoring safety reports for global regulatory submissions for Sciformix’s clients, including Canadian
Annual Reports (CARs), Addendum Reports (ACOs and Adhocs), Periodic Benefit Risk Evaluation Reports
(PBRERs), Periodic Safety Update Reports (PSURs), Periodic Adverse Drug Experience Reports (PADERs), Bridging
reports and other clinical documents
• Internal and external (client) communication & co-ordination to get the required inputs
• Generation of line listing from the database
• Well versed with the EU and USFDA regulations
• Timely escalation of unresolved issues to internal & External (client) points of contact
• Tracking and maintenance of metrics, performing and documenting quality checks
• Implementing and promoting use of consistent, efficient and quality processes to meet timelines and deliverables
according to requirements and standard operating procedures and assume accountability for the deliverables
• Resolution on issues affecting projectdeliverables and timely escalation of unresolved issues to internal and external
(client) points of contact
March2011 – April 2014 Associate Research Analyst, Thomson Reuters, Hyderabad
Thomson Reuters
Custom Information Services
• To write Individual Case Safety Report (ICSR) summaries with identifiable patient’s data with suspected or probable
adverse drug reaction to one or more medicinal products
• To handle responsibilities of reviewing and processing adverse events reported by investigators, including serious
adverse drug reactions and adverse events from published literature
• Reporting drug-specific adverse events for pharmacovigilance purposes
• Writing patient safety narratives for patients who discontinued due to AEs, SAEs, death or any other event of special
interest
• Quality analysis and review of safety narratives according to client provided guidelines and sources
• To perform the tasks of maintaining the safety database and perform coding of diseases as well as adverse events
using MeSH and MedRA dictionaries
Thomson Reuters
ISI Web of Knowledge platform
• Abstraction and standardized classification of life science data from clinical studies, journals, conferences, patents
and re reviews for the ISI Web of Knowledge platform
• In-depth indexing of major concepts, organisms, taxonomic groups, diseases, genes, pharmaceutical agents and
geographic locations discussed in each document
• Subject coverage: Pre-clinical and clinical research, methodology and instrumentation, environmental and consumer
issues, among others
• Sources:Research articles and reports oforiginal research,review articles, notes,letters,and meta-analyses, books
and book chapters, meeting reports and published abstracts of papers presented at meetings, and United States
patents in life sciences
PERSONAL SKILLS
- Ability to work in team and develop inter-personal skills
- Adaptability to new environment
- Ability to grasp and learn new skills and software quickly
- Good analytical and logical skills
- Excellent oral and communication skills
PERSONAL PROFILE
Name Naveen Kumar Pawar
Gender Male
Nationality Indian
Date of Birth 18th
July 1986
Age 29
Languages known English, Hindi, Tamil and Telugu
DECLARATION
I hereby declare that the above furnished information is true to the bestof my knowledge.
Naveen Kumar Pawar

Weitere ähnliche Inhalte

Was ist angesagt?

Evidence-based medicine databases
Evidence-based medicine databasesEvidence-based medicine databases
Evidence-based medicine databasesnabot
 
Evidencia de vida real en oncología
Evidencia de vida real en oncologíaEvidencia de vida real en oncología
Evidencia de vida real en oncologíaMauricio Lema
 
4th Annual Advancing the Pace of Chemical Risk Assessment
4th Annual Advancing the Pace of Chemical Risk Assessment4th Annual Advancing the Pace of Chemical Risk Assessment
4th Annual Advancing the Pace of Chemical Risk AssessmentMichelle Angrish
 
Clinical Research Jobs and Career Prospects
Clinical Research Jobs and Career ProspectsClinical Research Jobs and Career Prospects
Clinical Research Jobs and Career Prospectswww.CLINIINDIA.com .
 
FDA Guidance on the Distribution fo Reprints
FDA Guidance on the Distribution fo ReprintsFDA Guidance on the Distribution fo Reprints
FDA Guidance on the Distribution fo ReprintsDickson Consulting
 
Non randomized controlled trial
Non randomized controlled trial Non randomized controlled trial
Non randomized controlled trial HimikaRathi
 
When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...Effective Health Care Program
 
EUPATI Launch Meeing: Anders Olauson
EUPATI Launch Meeing: Anders OlausonEUPATI Launch Meeing: Anders Olauson
EUPATI Launch Meeing: Anders Olausonjangeissler
 
Secondary Evidence Based Medicine Rsources SC
Secondary Evidence Based Medicine Rsources SCSecondary Evidence Based Medicine Rsources SC
Secondary Evidence Based Medicine Rsources SCImad Hassan
 
Searching socialmediaforadverseevents
Searching socialmediaforadverseeventsSearching socialmediaforadverseevents
Searching socialmediaforadverseeventsAnn-Marie Roche
 
An introduction to evidence based medicine, Prof. Usama M.Fouda
An introduction to evidence based medicine, Prof. Usama M.FoudaAn introduction to evidence based medicine, Prof. Usama M.Fouda
An introduction to evidence based medicine, Prof. Usama M.Foudaumfrfouda
 
Careers in Medical Writing
Careers in Medical Writing Careers in Medical Writing
Careers in Medical Writing Amanda Strong
 
Consort 2010 explanation and elaboration (bmj)
Consort 2010 explanation and elaboration (bmj)Consort 2010 explanation and elaboration (bmj)
Consort 2010 explanation and elaboration (bmj)Luis Bravo(Marketing)
 
Medical Writing 101 (PWAC)
Medical Writing 101 (PWAC)Medical Writing 101 (PWAC)
Medical Writing 101 (PWAC)Amanda Strong
 
Biostatistics in R : Clinical Trial applications
Biostatistics in R : Clinical Trial applicationsBiostatistics in R : Clinical Trial applications
Biostatistics in R : Clinical Trial applicationsAvinash Chamwad
 
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...Medpace
 
Corey M. Raines Resume
Corey M. Raines ResumeCorey M. Raines Resume
Corey M. Raines ResumeCorey Raines
 

Was ist angesagt? (20)

Evidence-based medicine databases
Evidence-based medicine databasesEvidence-based medicine databases
Evidence-based medicine databases
 
Evidencia de vida real en oncología
Evidencia de vida real en oncologíaEvidencia de vida real en oncología
Evidencia de vida real en oncología
 
4th Annual Advancing the Pace of Chemical Risk Assessment
4th Annual Advancing the Pace of Chemical Risk Assessment4th Annual Advancing the Pace of Chemical Risk Assessment
4th Annual Advancing the Pace of Chemical Risk Assessment
 
Clinical Research Jobs and Career Prospects
Clinical Research Jobs and Career ProspectsClinical Research Jobs and Career Prospects
Clinical Research Jobs and Career Prospects
 
FDA Guidance on the Distribution fo Reprints
FDA Guidance on the Distribution fo ReprintsFDA Guidance on the Distribution fo Reprints
FDA Guidance on the Distribution fo Reprints
 
Non randomized controlled trial
Non randomized controlled trial Non randomized controlled trial
Non randomized controlled trial
 
When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...When to Select Observational Studies as Evidence for Comparative Effectivenes...
When to Select Observational Studies as Evidence for Comparative Effectivenes...
 
EUPATI Launch Meeing: Anders Olauson
EUPATI Launch Meeing: Anders OlausonEUPATI Launch Meeing: Anders Olauson
EUPATI Launch Meeing: Anders Olauson
 
Secondary Evidence Based Medicine Rsources SC
Secondary Evidence Based Medicine Rsources SCSecondary Evidence Based Medicine Rsources SC
Secondary Evidence Based Medicine Rsources SC
 
Searching socialmediaforadverseevents
Searching socialmediaforadverseeventsSearching socialmediaforadverseevents
Searching socialmediaforadverseevents
 
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...
PMED: APPM Workshop: From Real World Data to Real World Evidence - Richard Zi...
 
An introduction to evidence based medicine, Prof. Usama M.Fouda
An introduction to evidence based medicine, Prof. Usama M.FoudaAn introduction to evidence based medicine, Prof. Usama M.Fouda
An introduction to evidence based medicine, Prof. Usama M.Fouda
 
Careers in Medical Writing
Careers in Medical Writing Careers in Medical Writing
Careers in Medical Writing
 
Project
ProjectProject
Project
 
Consort 2010 explanation and elaboration (bmj)
Consort 2010 explanation and elaboration (bmj)Consort 2010 explanation and elaboration (bmj)
Consort 2010 explanation and elaboration (bmj)
 
Medical Writing 101 (PWAC)
Medical Writing 101 (PWAC)Medical Writing 101 (PWAC)
Medical Writing 101 (PWAC)
 
Reporting guidelines
Reporting guidelinesReporting guidelines
Reporting guidelines
 
Biostatistics in R : Clinical Trial applications
Biostatistics in R : Clinical Trial applicationsBiostatistics in R : Clinical Trial applications
Biostatistics in R : Clinical Trial applications
 
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
Webinar: Special Considerations for Managing Immuno-Oncology Studies: A New P...
 
Corey M. Raines Resume
Corey M. Raines ResumeCorey M. Raines Resume
Corey M. Raines Resume
 

Ähnlich wie Naveen_Pawar_Resume.doc

Webinar pv use case 23 march2016
Webinar pv use case 23 march2016Webinar pv use case 23 march2016
Webinar pv use case 23 march2016Ann-Marie Roche
 
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...Bhaswat Chakraborty
 
Evidence based medicine
Evidence based medicineEvidence based medicine
Evidence based medicineDrShrey Bhatia
 
List_of_Documents_Medical_Writing_Anjala_Sikri
List_of_Documents_Medical_Writing_Anjala_SikriList_of_Documents_Medical_Writing_Anjala_Sikri
List_of_Documents_Medical_Writing_Anjala_SikriANGELA7676
 
Topic – PSUR by Sourav Chander.pptx
Topic – PSUR by Sourav Chander.pptxTopic – PSUR by Sourav Chander.pptx
Topic – PSUR by Sourav Chander.pptxSouravChanderRajputt
 
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...ijtsrd
 
Redbook 2000: IV.B.3 Pathology Considerations in Toxicity Studies Toxicologic...
Redbook 2000: IV.B.3 Pathology Considerations in Toxicity StudiesToxicologic...Redbook 2000: IV.B.3 Pathology Considerations in Toxicity StudiesToxicologic...
Redbook 2000: IV.B.3 Pathology Considerations in Toxicity Studies Toxicologic...Dmitri Popov
 
passive_serviallance and responsibilities in pharmacovigilance pptx
passive_serviallance and responsibilities in pharmacovigilance pptxpassive_serviallance and responsibilities in pharmacovigilance pptx
passive_serviallance and responsibilities in pharmacovigilance pptxAyodhya Paradhe
 
Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...
Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...
Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...InsSilva801685
 
signaldetectionandmanagement-210803014643.pdf
signaldetectionandmanagement-210803014643.pdfsignaldetectionandmanagement-210803014643.pdf
signaldetectionandmanagement-210803014643.pdfdabloosaha
 
Signal detection and management
Signal detection and managementSignal detection and management
Signal detection and managementsekharbabu41
 

Ähnlich wie Naveen_Pawar_Resume.doc (20)

Anusha Kusuma_PV
Anusha Kusuma_PVAnusha Kusuma_PV
Anusha Kusuma_PV
 
Anusha Kusuma_PV
Anusha Kusuma_PVAnusha Kusuma_PV
Anusha Kusuma_PV
 
Webinar pv use case 23 march2016
Webinar pv use case 23 march2016Webinar pv use case 23 march2016
Webinar pv use case 23 march2016
 
Pharmacovigilance SME
Pharmacovigilance SMEPharmacovigilance SME
Pharmacovigilance SME
 
Clinical Study and Safety Reporting Activities Peivand Pirouzi 2011
Clinical Study and Safety Reporting Activities   Peivand Pirouzi 2011Clinical Study and Safety Reporting Activities   Peivand Pirouzi 2011
Clinical Study and Safety Reporting Activities Peivand Pirouzi 2011
 
Venkatesh_CV
Venkatesh_CVVenkatesh_CV
Venkatesh_CV
 
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
 
CV Dennis Fowler July 2014
CV  Dennis Fowler July 2014CV  Dennis Fowler July 2014
CV Dennis Fowler July 2014
 
Prospectus
ProspectusProspectus
Prospectus
 
Evidence based medicine
Evidence based medicineEvidence based medicine
Evidence based medicine
 
List_of_Documents_Medical_Writing_Anjala_Sikri
List_of_Documents_Medical_Writing_Anjala_SikriList_of_Documents_Medical_Writing_Anjala_Sikri
List_of_Documents_Medical_Writing_Anjala_Sikri
 
CV sukhreet latest
CV sukhreet latestCV sukhreet latest
CV sukhreet latest
 
Topic – PSUR by Sourav Chander.pptx
Topic – PSUR by Sourav Chander.pptxTopic – PSUR by Sourav Chander.pptx
Topic – PSUR by Sourav Chander.pptx
 
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
 
Redbook 2000: IV.B.3 Pathology Considerations in Toxicity Studies Toxicologic...
Redbook 2000: IV.B.3 Pathology Considerations in Toxicity StudiesToxicologic...Redbook 2000: IV.B.3 Pathology Considerations in Toxicity StudiesToxicologic...
Redbook 2000: IV.B.3 Pathology Considerations in Toxicity Studies Toxicologic...
 
passive_serviallance and responsibilities in pharmacovigilance pptx
passive_serviallance and responsibilities in pharmacovigilance pptxpassive_serviallance and responsibilities in pharmacovigilance pptx
passive_serviallance and responsibilities in pharmacovigilance pptx
 
clinical trials
clinical trialsclinical trials
clinical trials
 
Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...
Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...
Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...
 
signaldetectionandmanagement-210803014643.pdf
signaldetectionandmanagement-210803014643.pdfsignaldetectionandmanagement-210803014643.pdf
signaldetectionandmanagement-210803014643.pdf
 
Signal detection and management
Signal detection and managementSignal detection and management
Signal detection and management
 

Naveen_Pawar_Resume.doc

  • 1. Naveen Pawar NAVEEN KUMAR PAWAR E-mail: pnaveenkumar20@gmail.com Pune,India Contact no: +91-7030897089 Summary  Involved in writing and review of various safety reports for global regulatory submissions for Sciformix’s clients, including Canadian Annual Reports (CARs), Addendum Reports (ACOs and Adhocs), Periodic Benefit Risk Evaluation Reports (PBRERs), Periodic Safety Update Reports (PSURs), Periodic Adverse Drug Experience Reports (PADERs), Bridging reports and other clinical documents Education  M. Sc. (Biotechnology), PondicherryUniversity  B. Sc. (Biotechnology), Loyola Academy(Osmania University) Publications, Seminars & Presentations Naveen Kumar Pawar,N Arumugam. Leafextract of Centratherumpunctatum Cass.exhibits anti-microbial,anti-proliferative and anti-oxidant properties. Asian journal ofclinical and pharmaceutical research (published July2011). Work Experience April 2014 – Present Medical writer , Sciformix Technologies, Pune Sciformix Safety Writing and Regulatory Affairs • Preparing/Co-authoring safety reports for global regulatory submissions for Sciformix’s clients, including Canadian Annual Reports (CARs), Addendum Reports (ACOs and Adhocs), Periodic Benefit Risk Evaluation Reports (PBRERs), Periodic Safety Update Reports (PSURs), Periodic Adverse Drug Experience Reports (PADERs), Bridging reports and other clinical documents • Internal and external (client) communication & co-ordination to get the required inputs • Generation of line listing from the database • Well versed with the EU and USFDA regulations • Timely escalation of unresolved issues to internal & External (client) points of contact • Tracking and maintenance of metrics, performing and documenting quality checks • Implementing and promoting use of consistent, efficient and quality processes to meet timelines and deliverables according to requirements and standard operating procedures and assume accountability for the deliverables • Resolution on issues affecting projectdeliverables and timely escalation of unresolved issues to internal and external (client) points of contact March2011 – April 2014 Associate Research Analyst, Thomson Reuters, Hyderabad Thomson Reuters Custom Information Services • To write Individual Case Safety Report (ICSR) summaries with identifiable patient’s data with suspected or probable adverse drug reaction to one or more medicinal products • To handle responsibilities of reviewing and processing adverse events reported by investigators, including serious adverse drug reactions and adverse events from published literature • Reporting drug-specific adverse events for pharmacovigilance purposes • Writing patient safety narratives for patients who discontinued due to AEs, SAEs, death or any other event of special interest • Quality analysis and review of safety narratives according to client provided guidelines and sources • To perform the tasks of maintaining the safety database and perform coding of diseases as well as adverse events using MeSH and MedRA dictionaries Thomson Reuters ISI Web of Knowledge platform • Abstraction and standardized classification of life science data from clinical studies, journals, conferences, patents and re reviews for the ISI Web of Knowledge platform • In-depth indexing of major concepts, organisms, taxonomic groups, diseases, genes, pharmaceutical agents and geographic locations discussed in each document
  • 2. • Subject coverage: Pre-clinical and clinical research, methodology and instrumentation, environmental and consumer issues, among others • Sources:Research articles and reports oforiginal research,review articles, notes,letters,and meta-analyses, books and book chapters, meeting reports and published abstracts of papers presented at meetings, and United States patents in life sciences PERSONAL SKILLS - Ability to work in team and develop inter-personal skills - Adaptability to new environment - Ability to grasp and learn new skills and software quickly - Good analytical and logical skills - Excellent oral and communication skills PERSONAL PROFILE Name Naveen Kumar Pawar Gender Male Nationality Indian Date of Birth 18th July 1986 Age 29 Languages known English, Hindi, Tamil and Telugu DECLARATION I hereby declare that the above furnished information is true to the bestof my knowledge. Naveen Kumar Pawar